21 research outputs found
Aneurysm of antecubital vein: an unusual complication of peripheral intravenous cannulation
<p>Abstract</p> <p>Background</p> <p>Intravenous cannulation is a very common procedure. Venous aneurysm secondary to peripheral intravenous cannulation is extremely rare. Moreover, venous aneurysm can mimic other conditions and may confuse the issue.</p> <p>Case presentation</p> <p>We describe a case of a 45-year-old woman who was referred with the diagnosis of varicose vein of right arm. A history of intravenous cannulation at the same site was noted that raised suspicion. The swelling was compressible and turned out to be a venous aneurysm. The lesion was completely excised. Postoperative recovery was uneventful. Histology findings were in conformity with the preoperative diagnosis.</p> <p>Conclusion</p> <p>Caution should be exercised in diagnosing varicose vein at a site that bears a history of intravenous cannulation. The case also raises an important issue regarding consent. Should patients undergoing peripheral intravenous cannulation be warned of this rare complication?</p
Glasgow Coma Scale score at intensive care unit discharge predicts the 1-year outcome of patients with severe traumatic brain injury
Iatrogenic Superficial External Pudendal Artery Pseudoaneurysm: Treatment with Doppler US-Guided Compression
Obesity, smoking status and their relationships in selected population groups
Background. Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health.
Obesity is associated with many chronic diseases, including cardiovascular disease and diabetes, and recently the role of
overweight and obesity in lung disease has received new interest. Chronic obstructive lung disease is the third-leading
cause of death globally, and both obesity and diet appear to play roles in its pathophysiology. Cross-sectional studies
have demonstrated an inverse association between obesity and the prevalence of chronic obstructive pulmonary disease
(COPD).
Objective. This study aims to evaluate the relationship between smoking, lipid profile and obesity (body composition
changes) in a selected groups of population (30 non-smokers, 30 smokers and 60 COPD patients).
Material and Methods. We evaluated fat mass, fat free mass, body mass index and lipid profile in a group of 120 randomly
selected probands (60 COPD patients; 30 smokers without COPD; 30 non-smokers without COPD) to identify possible
negative relationships of smoking to body composition. To the measurement of fat mass (FM) and fat free mass (FFM)
was used a device Bodystat Quadscan 4000 (Bodystat Ltd, British Isles). The device works by using four-frequency
bioelectrical impedance analysis. Laboratory parameters as total cholesterol (T-C), high-density cholesterol (HDL-C),
low-density cholesterol (LDL-C) and triacylglycerols (TG) were investigated by automated clinical chemistry analyzer
LISA 200th. The measured values were statistically processed and evaluated in a statistical program STATISTICA Cz.
Version 7.1. (Kruskall-Wallis test).
Results. A comparison of the mean fat mass we found statistically highly significant differences between the group of
COPD patients and non-smokers (P <0.001) and insignificant differences (P ≥ 0.05) between the other groups of our
experiment. A comparison of the mean fat mass values of all three groups of the experiment shows a steady increase in
fat from non-smokers (17.66 ± 10.04 kg) to COPD patients with the highest mean value (25.08 ± 10.14 kg). In the group
of COPD patients we recorded the lowest average value of FFM (51.76 ± 13.84 kg), in group of smokers the middle (56.06
± 10.76 kg) and in non-smokers the highest average value of FFM (59.91 ± 9.90 kg) at relatively the same body weight
in the groups. Based on calculated body mass index (BMI), we found in group of COPD patients overweight in 15 cases
(25%), obesity in 7 patients (11.67%), severe obesity in 14 patients (23.3%) and morbid obesity in 2 patients (3.33%); in
the group of smokers overweight in 16 cases (53.33%), obesity in 5 cases (16.6%) and severe obesity in 1 case (3.33%);
in non-smokers we recording overweight in 14 cases (46.67%), obesity in 5 cases (16.67%) and severe obesity in 2 cases
(6.67%). In the lipid profile of the monitored groups of probands, we observed statistically significant differences only for
LDL cholesterol (LDL-C). There was a statistically significant difference (P <0.001) between the group with COPD and
smokers, as well as between the group of smokers and non-smokers (P < 0.05).
Conclusions. In the vast majority of patients with COPD, the lung damage that leads to COPD is caused by long-term
cigarette smoking. The presence and absence of risk factors such as smoking, inappropriate lipid profile and obesity
(amount of fat mass) in selected population groups were observed. Additional studies to explore both the quantitative
and qualitative changes in body composition with disease process of COPD are required
Biochemical parameters as monitoring markers of the inflammatory reaction by patients with chronic obstructive pulmonary disease (COPD)
Background. Chronic obstructive pulmonary disease (COPD) is an airway inflammatory disease caused by inhalation of
toxic particles, mainly cigarette smoking, and now is accepted as a disease associated with systemic characteristics.
Objective. The aim of this work was to investigate and compare selected biochemical parameters in patients with and
without COPD.
Material and Methods. Observation group consisted of clinically stable patients with COPD (n = 60). The control group
was healthy persons from the general population, without COPD, who were divided into two subgroups – smokers (n = 30)
and non-smokers (n = 30). Laboratory parameters were investigated by automated clinical chemistry analyzer LISA 200th.
Results. Albumin in our measurements showed an average value of 39.55 g.l-1 in the patient population; 38.89 g.l-1 in
smokers and in non-smokers group 44.65 g.l-1. The average value of pre-albumin in the group of patients was 0.28 ± 0.28 g.l-1
and 0.30 ± 0.04 g.l-1 in smokers group. The average value of the orosomucoid in patients was about 1.11 ± 0.90 mg.ml-1. In the
group of smokers, the mean value of orosomucoid was 0.60 ± 0.13 mg.ml-1. The level of C-reactive protein (CRP) in the patient
group reached an average value of 15.31 ± 22.04 mg.l-1, in the group of smokers was 5.18 ± 4.58 mg. l-1. Prognostic inflammatory
and nutritional index (PINI) in the group of patients showed a mean value of 4.65 ± 10.77 and 0.026 ± 0.025 in smokers.
Conclusions. The results of this work show, that the values of index PINI in COPD patients are significantly higher than
in smokers (P <0.001). This along with other monitored parameters indicative inflammation as well as a catabolic process
that occurs in the organism of patients with COPD.Wprowadzenie. Przewlekła obturacyjna choroba płuc (POChP) jest chorobą zapalną dróg oddechowych spowodowaną
inhalacją toksycznych związków chemicznych, pochodzących głównie z palenia papierosów, która charakteryzowana jest
jako choroba ogólnoustrojowa.
Cel. Celem niniejszej pracy było oznaczenie we krwi chorych na POChP wybranych parametrów biochemicznych stanu
zapalnego oraz porównanie ich stężenia w grupie zdrowych ludzi bez POChP.0
Materiał i metody. Grupa badana składała się z klinicznie stabilnych pacjentów z POChP (n = 60). Grupę kontrolną stanowili
zdrowi pacjenci z populacji generalnej, bez POChP, którzy zostali podzieleni na dwie podgrupy – palaczy papierosów (n = 30)
i niepalących (n = 30). Parametry biochemiczne oznaczano z wykorzystaniem automatycznego analizatora LISA 200.
Wyniki. Średnie stężenie albumin w grupie chorych wynosiło 39.55 g.l-1 ; w grupie zdrowych palących 38.89 g.l-1
a w grupie zdrowych niepalących 44.65 g.l-1. Średnie stężenie pre-albuminy w poszczególnych grupach pacjentów
i zdrowych palących wynosiło odpowiednio 0.28 ± 0.28 g.l-1 oraz 0.30 ± 0.04 g.l-1. Stężenie orosomukoidu w grupie
chorych wynosiło 1.11 ± 0.90 mg.ml-1. W grupie palących zdrowych osób średnio 0.60 ± 0.13 mg.ml-1. Stężenie białka Creaktywnego
(CRP) w grupie chorych na POChP wynosiło 15.31 ± 22.04 mg.l-1, a w grupie palących 5.18 ± 4.58 mg. l-1.
Prognostyczny wskaźnik odżywienia i stanu zapalnego - PINI (Prognostic Inflammatory and Nutritional Index) w grupie
pacjentów wynosił średnio 4.65 ± 10.77 a w grupie osób palących 0.026 ± 0.025.
Wnioski: Wyniki niniejszych badań wykazały, że wartości PINI u pacjentów z POChP były statystycznie wyższe
(p <0,001) niż w grupie osób palących. Uzyskane wyniki wraz z innymi monitorowanymi parametrami świadczą o stanie
zapalnym jak również o procesie katabolicznym, który występuje w organizmie pacjentów z POChP
Analysis of visceral fat in patients with chronic obstructive pulmonary disease (COPD)
Background. Cigarette smoking is a major public health problem, which leads to the formation of chronic obstructive
pulmonary disease (COPD) and is one of the main causes of avoidable death and disability worldwide.
Objective. The aim of study was analysis and comparison of the visceral fat in the body of the three groups of subjects
(non-smokers, smokers and COPD patients) by Tanita Viscan 140.
Material and Methods. The control group was composed of: (1) non-smokers (n=30), consisted of 13 males (43.4%)
and 17 women (56.6%) - the average age was 52 ± 6.51 years and (2) smokers (n=30), consisted of 12 men (40%) and 18
women (60%) – the average age 46.53 ± 9.22 years. Study group consisted of patients with COPD (n=60), which consisted
of 48 men (80%) and 12 women (20%). Mean age was 69.25 ± 9.90 years. The measurement of visceral fat by Tanita Viscan
device 140, which uses bioelectrical impedance analysis to measure fat in the abdomen of the patient in the supine position.
Results. High levels of visceral fat (women from 36.9% to 52.3% and more, men from 27.1% to 40.3% or more) were
observed in 19 patients (3 women and 16 men), with 19 smokers (10 women and 9 men) and non-smokers in 22 subjects
(10 women and 12 men). The average value of waist circumference measured with a Tanita Viscan 140 was in the group
of patients 96.38 ± 12.27 cm, in the group of smokers 95.23 ± 10.12 cm and in group of non-smokers 96.86 ± 10.88 cm.
Conclusions. The results of our work are of great importance for the health assessment not only among patients with COPD
but also in the group of smokers. Therefore it would be appropriate to remind the general public, eg. by campaign for
chronic obstructive pulmonary disease and its serious complications and reduce the life quality of these patients and thus
help protect human health and in particular young people from the harmful effects of tobacco products.Wprowadzenie. Palenie papierosów jest poważnym problemem zdrowotnym, który prowadzi do powstawania przewlekłej
obturacyjnej choroby płuc (POChP) i jest jednym z głównych przyczyn śmierci i niepełnosprawności na całym świecie.
Cel badań. Dokonano pomiaru zawartości w organizmie tłuszczu trzewnego za pomocą urządzenia Tanita Viscan 140,
który wykorzystuje metodę bioelektrycznej impedancji do pomiaru tkanki tłuszczowej w jamie brzusznej pacjenta w pozycji
leżącej.
Materiał i metody. Grupa kontrolna składała się z osób niepalących (n = 30), w tym z 13 mężczyzn (43,4%) i 17 kobiet
(56,6%) - średni wiek wynosił 52 ± 6,51 roku. Grupa palaczy papierosów (n = 30) składała się z 12 mężczyzn (40%) i 18
kobiet (60%) - średni wiek 46,53 ± 9,22 roku. Badaniem objęto również grupę pacjentów z POChP (n = 60), która składała
się z 48 mężczyzn (80%) i 12 kobiet (20%). Średni wiek wynosił 69,25 ± 9,90 roku. Dokonano pomiaru w organizmie
zawartości tłuszczu trzewnego za pomocą urządzenia Tanita Viscan 140, który wykorzystuje metodę bioelektrycznej impedancji
do pomiaru tkanki tłuszczowej w jamie brzusznej pacjenta w pozycji leżącej.
Wyniki. Wykazano wysoki poziom tłuszczu trzewnego (w zakresie od 36,9% do 52,3% u kobiet i w zakresie 27,1% do
40,3% u mężczyzn) u 19 chorych (3 kobiety i 16 mężczyzn) na przewlekłą obturacyjną chorobę płuc zaobserwowano, u 19
palaczy (10 kobiet i 9 mężczyzn ) i w grupie 22 niepalących osób (10 kobiet i 12 mężczyzn). Średnia wartość obwodu talii mierzona za pomocą urządzenia Tanita Viscan 140 wynosiła: w grupie pacjentów z POChP 96,38 ± 12,27 cm, w grupie
palaczy 95,23 ± 10,12 cm, a w grupie niepalących 96.86 ± 10,88 cm.
Wnioski. Wyniki pracy mają istotne znaczenie dla oceny stanu zdrowia nie tylko wśród pacjentów z POChP, ale także
w grupie osób palących. Wskazana byłaby edukacja społeczeństwa poprzez organizowanie kampanii na temat poważnych
powikłań zdrowotnych i obniżeniu jakości życia pacjentów z POChP, aby w ten sposób chronić zdrowie ludzi, szczególnie
młodych, przed szkodliwym działaniem palenia produktów tytoniowych
The relationship between seeds consumption, lipid profile and body mass index among patients with cardiovascular diseases
Background. Cardiovascular disease (CVD) is the leading cause of death worldwide and largely preventable through
improving diet quality and other lifestyle factors. In recent years, dietary recommendations have shifted towards diets
high in plant-based foods and low in animal-based foods for the prevention of chronic diseases.
Objective. This study aims to evaluate the relationship between seeds consumption, lipid profile and body mass index
(BMI) in a group of 889 (313 female and 576 male) randomly selected patients hospitalized in the Nitra Cardio Center,
Slovakia.
Material and Methods. The data necessary for the evaluation the relationship between seeds consumption, lipid profiles
and BMI were obtained by a questionnaire method in closed-ended format. Data collection was carried out simultaneously
with the anthropometric and biochemical examinations of the respondents ensured by the Nitra Cardio Center. The
following parameters were assessed in the blood: total cholesterol (T-C), low-density cholesterol (LDL-C), high-density
cholesterol (HDL-C), triglycerides (TG), and glucose (GLU). Comparisons between groups were made utilizing one-way
analysis of variance (ANOVA) followed by Tukey's post hoc test.
Results. Respondents indicated pumpkin seeds as the most commonly consumed seeds (45.19% of women and 53.06%
of men) and their preference did not cause changes in lipid profile. Women who consume seeds 1-2 times/month had
significantly lower levels of T-C and LDL-C compared to women non-consuming seeds (P < 0.05). In men, we did not
observed any changes in lipid profile. The lowest BMI in women was associated with flaxseed preference and in men
with sunflower preference. Increasing frequency of seeds consumption of women and men did not cause changes in BMI.
Conclusions. Based on beneficial effects of seeds on cardiovascular risk factors, it seems that seeds consumption can be
considered as a useful therapeutic approach for reducing lipid profile and body mass index